Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Trastornos del movimiento Movement disorders 321 artículos Viendo del 161 al 200 de 321 artículos
Pub MED

Vascular risk factors and depression in Parkinson's disease.NUEVO

Ou R, Wei Q, Hou Y, Yuan X, Song W, Cao B, Liu H, Zhang L, Chen Y, Shang H.
Eur J Neurol. 2017 Dec 22. doi: 10.1111/ene.13551. [Epub ahead of print]
Pub MED

Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.NUEVO

Flønes IH, Fernandez-Vizarra E, Lykouri M, Brakedal B, Skeie GO, Miletic H, Lilleng PK, Alves G, Tysnes OB, Haugarvoll K, Dölle C, Zeviani M, Tzoulis C.
Acta Neuropathol. 2017 Dec 21. doi: 10.1007/s00401-017-1794-7. [Epub ahead of print]
Pub MED

Stem Cell Transplantation and Physical Exercise in Parkinson's Disease, a Literature Review of Human and Animal Studies.NUEVO

Hurtado JDC, Sánchez JPB, Nunes RB, de Oliveira AA.
Stem Cell Rev. 2017 Dec 21. doi: 10.1007/s12015-017-9798-1. [Epub ahead of print] Review.
Pub MED

Correction to: Efficacy and safety of rotigotine in elderly patients with Parkinson's disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials.NUEVO

Nomoto M, Iwaki H, Kondo H, Sakurai M.
J Neurol. 2017 Dec 21. doi: 10.1007/s00415-017-8706-6. [Epub ahead of print]
Pub MED

Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson's disease.NUEVO

Chan DKY, Xu YH, Chan LKM, Braidy N, Mellick GD.
Transl Neurodegener. 2017 Dec 20;6:33. doi: 10.1186/s40035-017-0104-6. eCollection 2017. Review.
Pub MED

The effect of istradefylline for Parkinson's disease: A meta-analysis.NUEVO

Sako W, Murakami N, Motohama K, Izumi Y, Kaji R.
Sci Rep. 2017 Dec 21;7(1):18018. doi: 10.1038/s41598-017-18339-1.
Pub MED

A Rare Coexistence of Pheochromocytoma and Parkinson's Disease With Diagnostic Challenges : A Case Report.NUEVO

Matsumura E, Sekiya M, Omoto M, Santo K, Shikama A, Kuba M, Sugano Y, Iwasaki H, Yatou S, Sato T, Hara H, Takekoshi K, Suzuki H, Shimano H.
Intern Med. 2017 Dec 21. doi: 10.2169/internalmedicine.9242-17. [Epub ahead of print]
Pub MED

Dopaminergic Medication Shifts the Balance Between Going and Stopping in Parkinson's Disease.NUEVO

Wylie SA, van Wouwe NC, Godfrey SG, Bissett PG, Logan GD, Kanoff KE, Claassen DO, Neimat JS, van den Wildenberg WPM.
Neuropsychologia. 2017 Dec 18. pii: S0028-3932(17)30505-5. doi: 10.1016/j.neuropsychologia.2017.12.032. [Epub ahead of print]
Pub MED

Novel Parkinson's disease risk loci identified through a meta-analysis of genome-wide association studies.NUEVO

Liu Z, Tang B.
Mov Disord. 2017 Dec 21. doi: 10.1002/mds.27276. [Epub ahead of print] No abstract available.
Pub MED

Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double-blind study.NUEVO

Bouthour W, Wegrzyk J, Momjian S, Péron J, Fleury V, Tomkova Chaoui E, Horvath J, Boëx C, Lüscher C, Burkhard PR, Krack P, Zacharia A.
Mov Disord. 2017 Dec 21. doi: 10.1002/mds.27265. [Epub ahead of print]
Pub MED

Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum and substantia nigra in Parkinson's disease rat model.NUEVO

Salama RM, Tadros MG, Schaalan MF, Bahaa N, Abdel-Tawab AM, Khalifa AE.
J Cell Physiol. 2017 Dec 21. doi: 10.1002/jcp.26412. [Epub ahead of print]
Pub MED

Perceptions of balance and falls following a supervised training intervention - a qualitative study of people with Parkinson's disease.NUEVO

Leavy B, Berntsson J, Franzén E, Skavborg Roaldson K.
Disabil Rehabil. 2017 Dec 21:1-7. doi: 10.1080/09638288.2017.1417498. [Epub ahead of print]
Pub MED

Leucine rich repeat kinase knockout (LRRK KO) mouse model: Linking pathological hallmarks of inherited and sporadic Parkinson's disease.NUEVO

Roosen DA, Singleton AB.
Mov Disord. 2017 Dec 19. doi: 10.1002/mds.27267. [Epub ahead of print] No abstract available.
Pub MED

Parkinson Disease.NUEVO

Zafar S, Yaddanapudi SS.
2017 Dec 4. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
Pub MED

DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice.NUEVO

Chen Y, Jiang M, Li L, Ye M, Yu M, Zhang L, Ge B, Xu W, Wei D.
Mol Med Rep. 2017 Dec 20. doi: 10.3892/mmr.2017.8332. [Epub ahead of print]
Pub MED

Subthalamic deep brain stimulation and trunk posture in Parkinson's disease.NUEVO

Artusi CA, Zibetti M, Romagnolo A, Rizzone MG, Merola A, Lopiano L.
Acta Neurol Scand. 2017 Dec 29. doi: 10.1111/ane.12889. [Epub ahead of print]
Pub MED

Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease.NUEVO

Duprez J, Houvenaghel JF, Drapier S, Auffret M, Drapier D, Robert G, Vérin M, Sauleau P.
J Neurol. 2017 Dec 28. doi: 10.1007/s00415-017-8721-7. [Epub ahead of print]
Pub MED

Exercise response in Parkinson's disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trial.NUEVO

Mavrommati F, Collett J, Franssen M, Meaney A, Sexton C, Dennis-West A, Betts JF, Izadi H, Bogdanovic M, Tims M, Farmer A, Dawes H.
BMJ Open. 2017 Dec 26;7(12):e017194. doi: 10.1136/bmjopen-2017-017194.
Pub MED

Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease.NUEVO

Giordano N, Iemolo A, Mancini M, Cacace F, De Risi M, Latagliata EC, Ghiglieri V, Bellenchi GC, Puglisi-Allegra S, Calabresi P, Picconi B, De Leonibus E.
Brain. 2017 Dec 21. doi: 10.1093/brain/awx351. [Epub ahead of print]
Pub MED

Examining alterations in GABA concentrations in the basal ganglia of patients with Parkinson's disease using MEGA-PRESS MRS.NUEVO

Elmaki EEA, Gong T, Nkonika DM, Wang G.
Jpn J Radiol. 2017 Dec 26. doi: 10.1007/s11604-017-0714-z. [Epub ahead of print]
Pub MED

Autonomic dysfunction in Parkinson's disease: A prospective cohort study.NUEVO

Merola A, Romagnolo A, Rosso M, Suri R, Berndt Z, Maule S, Lopiano L, Espay AJ.
Mov Disord. 2017 Dec 26. doi: 10.1002/mds.27268. [Epub ahead of print]
Pub MED

Analysis of variant rs3794087 in SLC1A2 and Parkinson's disease in a Chinese Han population: a case-control study and meta-analysis.NUEVO

Cheng Y, Mao CY, Liu YT, Li F, Yang J, Liu H, Zhang C, Wang YL, Wu J, Shi CH, Xu YM.
Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31018-2. doi: 10.1016/j.neulet.2017.12.045. [Epub ahead of print]
Pub MED

Effects of wrist weights on kinematic and myographic movement characteristics during a reaching task in individuals with Parkinson's disease.NUEVO

Li KY, Hsiao YP, Chen RS, Wu CY.
Arch Phys Med Rehabil. 2017 Dec 21. pii: S0003-9993(17)31404-1. doi: 10.1016/j.apmr.2017.11.009. [Epub ahead of print]
Pub MED

MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.NUEVO

Li D, Yang H, Ma J, Luo S, Chen S, Gu Q.
Hum Cell. 2017 Dec 22. doi: 10.1007/s13577-017-0187-5. [Epub ahead of print]
Pub MED

High-Intensity Exercise Acutely Increases Substantia Nigra and Prefrontal Brain Activity in Parkinson's Disease.NUEVO

Kelly NA, Wood KH, Allendorfer JB, Ford MP, Bickel CS, Marstrander J, Amara AW, Anthony T, Bamman MM, Skidmore FM.
Med Sci Monit. 2017 Dec 23;23:6064-6071.
Pub MED

Running wheel exercise reduces α-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease.NUEVO

Zhou W, Barkow JC, Freed CR.
PLoS One. 2017 Dec 22;12(12):e0190160. doi: 10.1371/journal.pone.0190160. eCollection 2017.
Pub MED

Parkinson disease: What goes around comes around: cognitive impairment as prodromal parkinsonism?NUEVO

Compta Y, Martí MJ.
Nat Rev Neurol. 2017 Dec;13(12):709-710. doi: 10.1038/nrneurol.2017.159. Epub 2017 Nov 10. No abstract available.
Pub MED

Comment: β-Amyloid pathology and Parkinson disease.NUEVO

Dodel R.
Neurology. 2017 Dec 5;89(23):2339. doi: 10.1212/WNL.0000000000004756. Epub 2017 Nov 8. No abstract available.
Pub MED

Observations on a 2-Step Approach to Screening for Parkinson Disease-Reply.NUEVO

Jennings D, Siderowf A, Marek K.
JAMA Neurol. 2017 Dec 1;74(12):1506-1507. doi: 10.1001/jamaneurol.2017.3208. No abstract available.
Pub MED

Differential impairments of upper and lower limb movements influence action verb processing in Parkinson disease.NUEVO

Roberts A, Nguyen P, Orange JB, Jog M, Nisbet KA, McRae K.
Cortex. 2017 Dec;97:49-59. doi: 10.1016/j.cortex.2017.09.022. Epub 2017 Oct 6.
Pub MED

Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients.NUEVO

Siciliano M, Trojano L, De Micco R, De Mase A, Garramone F, Russo A, Tedeschi G, Tessitore A.
Parkinsonism Relat Disord. 2017 Dec;45:63-68. doi: 10.1016/j.parkreldis.2017.10.004. Epub 2017 Oct 9.
Pub MED

Impaired Cognition and the Risk of Parkinson Disease: Trouble in Mind.NUEVO

Brown EG, Tanner CM.
JAMA Neurol. 2017 Dec 1;74(12):1398-1400. doi: 10.1001/jamaneurol.2017.1474. No abstract available.
Pub MED

Visual System Involvement in Patients with Newly Diagnosed Parkinson Disease.NUEVO

Arrigo A, Calamuneri A, Milardi D, Mormina E, Rania L, Postorino E, Marino S, Di Lorenzo G, Anastasi GP, Ghilardi MF, Aragona P, Quartarone A, Gaeta M.
Radiology. 2017 Dec;285(3):885-895. doi: 10.1148/radiol.2017161732. Epub 2017 Jul 11.
Pub MED

Neuroprotective effects of astragaloside IV on Parkinson disease models of mice and primary astrocytes.NUEVO

Xia L, Guo D, Chen B.
Exp Ther Med. 2017 Dec;14(6):5569-5575. doi: 10.3892/etm.2017.5238. Epub 2017 Sep 29.
Pub MED

Observations on a 2-Step Approach to Screening for Parkinson Disease.NUEVO

Noyce AJ, Lees A.
JAMA Neurol. 2017 Dec 1;74(12):1506. doi: 10.1001/jamaneurol.2017.3202. No abstract available.
Pub MED

Parkinson disease: Caffeine and nicotine do not provide symptomatic relief in Parkinson disease.NUEVO

Wood H.
Nat Rev Neurol. 2017 Dec;13(12):707. doi: 10.1038/nrneurol.2017.155. Epub 2017 Oct 23. No abstract available.
Pub MED

Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease.NUEVO

West AB.
Exp Neurol. 2017 Dec;298(Pt B):236-245. doi: 10.1016/j.expneurol.2017.07.019. Epub 2017 Jul 29. Review.
Pub MED

Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings.NUEVO

Cook L, Schulze J.
J Genet Couns. 2017 Dec;26(6):1165-1172. doi: 10.1007/s10897-017-0123-6. Epub 2017 Jun 30.
Pub MED

Targeting urate to reduce oxidative stress in Parkinson disease.NUEVO

Crotty GF, Ascherio A, Schwarzschild MA.
Exp Neurol. 2017 Dec;298(Pt B):210-224. doi: 10.1016/j.expneurol.2017.06.017. Epub 2017 Jun 13. Review.
Pub MED

Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis.NUEVO

Bajaj S, Krismer F, Palma JA, Wenning GK, Kaufmann H, Poewe W, Seppi K.
PLoS One. 2017 Dec 29;12(12):e0189897. doi: 10.1371/journal.pone.0189897. eCollection 2017.
Viendo del 161 al 200 de 321 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.